Détail de l'auteur
Auteur Philip O. Anderson |
Documents disponibles écrits par cet auteur (58)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : texte imprimé
Academy of Breastfeeding Medicine, Auteur ; Margaret M. Fleming, Auteur ; Katrina B. Mitchell, Auteur ; Philip O. Anderson, Auteur |Breastfeeding women may be required to undergo diagnostic imaging and/or nuclear medicine procedures at any point during lactation. Many women report being incorrectly instructed to discard (pump and dump) their breast milk or stop breastfeedi[...]Article : texte imprimé
Few comprehensive studies have been published on adverse drug reactions (ADRs) in breastfed infants from maternal medications. This column reviews the findings of two articles,1,2 plus seven additional articles published since the most recent ar[...]Article : texte imprimé
Use of alcohol in moderate amounts, for example, one drink with a meal, is unlikely to harm a breastfed infant as long as breastfeeding or pumping does not take place too soon after alcohol intake. Waiting 22.5 hours per drink will minimize inf[...]Article : texte imprimé
Occasionally an adverse drug reaction in a nursing infant is reported and becomes an urban legend that expands beyond reasonable limits. Such was the case of severe postoperative bleeding in a 4-week-old infant whose mother was taking the oral[...]Article : texte imprimé
Although many classes of drugs have been used for nausea and vomiting, few of the individual drugs have been studied well. Most of these drugs are used only for short periods of time, limiting risk to the breastfed infant. However, some commonly[...]Article : texte imprimé
Most antiepileptic drugs that have breastfeeding information reported appear to be acceptable to use during breastfeeding as single agents. Long-term follow-up data indicate that maternal carbamazepine, lamotrigine, phenytoin, and valproate caus[...]Article : texte imprimé
Many drugs are being investigated for treatment of COVID-19. The Medical Letter on Drugs and Therapeutics maintains an excellent, periodically updated and well-referenced table of anti-COVID-19 drugs that is free to download.1 Additional informa[...]Article : texte imprimé
The most commonly used antirejection drugs used after organ transplantation, cyclosporine, tacrolimus, corticosteroids, azathioprine and probably rituximab, are acceptable during breastfeeding. However, they should be used with caution while nur[...]Article : texte imprimé
Perhaps of greater immediate concern in the United States is the treatment of season influenza. As of February 21, 2020, 342 women of childbearing age (1544 years) had been hospitalized in the United States with influenza during the current flu[...]Article : texte imprimé
Breastfeeding is discouraged in women with HIV in high-income countries, but this guidance is beginning to be questioned by some. Although transmission of HIV infection to infants is low with appropriate therapy, it is not zero. U.S. guidelines [...]Article : texte imprimé
Older drugs for MS, such as glatiramer, interferon beta, IVIG and methylprednisolone, appear to be acceptable to use during breastfeeding. The newer monoclonal antibodies, natalizumab and rituximab appear promising in breastfeeding, but safety i[...]Article : texte imprimé
Most drugs used in the treatment of inflammatory bowel disease are compatible with breastfeeding. One exception is tofacitinib that requires cessation of breastfeeding if it is used. The use of weekly methotrexate is controversial. Although no a[...]Article : texte imprimé
The complex issues surrounding cannabis* use during breastfeeding have been well detailed by Mourh and Rowe in this issue of Breastfeeding Medicine.1 One topic that requires some amplification is that of assay methodology. The high fat solubilit[...]Article : texte imprimé
Choosing Medication Alternatives During Breastfeeding, Avoiding Alternative Facts : LactMed ® Update
Most drugs studied in nursing mothers present a low risk for the breastfed infant. But some drugs have more suitable alternatives available, often because of more extensive published safety data. In these cases, similar medications are listed in[...]